Fertility treatment may alter blood clot risk, study warns

NCT ID NCT04166825

First seen Jan 06, 2026 · Last updated Jun 22, 2026 · Updated 41 times

Summary

This study looks at how different ovarian stimulation protocols affect blood clotting in 300 infertile women, including those with endometriosis. Researchers will measure clot formation and breakdown before and after treatment. The goal is to understand which protocols pose higher clotting risks, helping guide safer fertility care.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for ENDOMETRIOSIS are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Contacts and locations

Locations

  • Department of Gynecological Endocrinology Jagiellonian University Medical College

    RECRUITING

    Krakow, Małopolska, 30-501, Poland

    Contact

    Contact Phone: •••-•••-•••• Email: •••••@•••••

    Contact

    Contact

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

What this could lead to

If successful, this could help doctors choose safer ovarian stimulation protocols for infertile women, especially those with endometriosis, by understanding blood clot risks.

What could go wrong

This is an observational study, not a treatment trial. It only measures changes in blood clotting, so it won't directly improve fertility or reduce clot risks.

Conditions

The condition(s) this trial relates to.

endometriosis female infertility infertility disorder thrombotic disease

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.